ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Metabolic Disease Drugs Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-10X10251
Home | Market Reports | Health| Pharmacy
Global Metabolic Disease Drugs Market Research Report 2022
BUY CHAPTERS

Global Metabolic Disease Drugs Market Research Report 2025

Code: QYRE-Auto-10X10251
Report
February 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Beohrigher Ingelheim
Kowa
Kythera
Fuji yakuhin
LG Life Science
Metsubishi Tanabe Pharma

Metabolic Disease Drugs Market Size

The global market for Metabolic Disease Drugs was valued at US$ 98580 million in the year 2024 and is projected to reach a revised size of US$ 191560 million by 2031, growing at a CAGR of 10.1% during the forecast period.

Metabolic Disease Drugs Market

Metabolic Disease Drugs Market

Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.
The Metabolic Disorders Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders related to metabolism, such as diabetes, obesity, hyperlipidemia, and thyroid disorders. This market encompasses various therapeutic areas including antidiabetic drugs, lipid-lowering agents, and thyroid hormone replacements. The Metabolic Disorders Drugs market has been experiencing significant growth due to factors such as the increasing prevalence of metabolic disorders globally, sedentary lifestyles, and unhealthy dietary habits. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of metabolic disorders and improving healthcare infrastructure.
This report aims to provide a comprehensive presentation of the global market for Metabolic Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolic Disease Drugs.
The Metabolic Disease Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Metabolic Disease Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metabolic Disease Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Metabolic Disease Drugs Market Report

Report Metric Details
Report Name Metabolic Disease Drugs Market
Accounted market size in year US$ 98580 million
Forecasted market size in 2031 US$ 191560 million
CAGR 10.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Life Science, Metsubishi Tanabe Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Metabolic Disease Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Metabolic Disease Drugs Market growing?

Ans: The Metabolic Disease Drugs Market witnessing a CAGR of 10.1% during the forecast period 2025-2031.

What is the Metabolic Disease Drugs Market size in 2031?

Ans: The Metabolic Disease Drugs Market size in 2031 will be US$ 191560 million.

Who are the main players in the Metabolic Disease Drugs Market report?

Ans: The main players in the Metabolic Disease Drugs Market are Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Beohrigher Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Life Science, Metsubishi Tanabe Pharma

What are the Application segmentation covered in the Metabolic Disease Drugs Market report?

Ans: The Applications covered in the Metabolic Disease Drugs Market report are Hospital Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Metabolic Disease Drugs Market report?

Ans: The Types covered in the Metabolic Disease Drugs Market report are Glycogen Metabolism Disease Drug, Lipid Metabolism Disease Drug, Amino Acid Metabolism Drug, Other

Recommended Reports

Metabolic Disorder Drugs

Rare & Genetic Diseases

Cardio & Neuro Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metabolic Disease Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Glycogen Metabolism Disease Drug
1.2.3 Lipid Metabolism Disease Drug
1.2.4 Amino Acid Metabolism Drug
1.2.5 Other
1.3 Market by Application
1.3.1 Global Metabolic Disease Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Metabolic Disease Drugs Market Perspective (2020-2031)
2.2 Global Metabolic Disease Drugs Growth Trends by Region
2.2.1 Global Metabolic Disease Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Metabolic Disease Drugs Historic Market Size by Region (2020-2025)
2.2.3 Metabolic Disease Drugs Forecasted Market Size by Region (2026-2031)
2.3 Metabolic Disease Drugs Market Dynamics
2.3.1 Metabolic Disease Drugs Industry Trends
2.3.2 Metabolic Disease Drugs Market Drivers
2.3.3 Metabolic Disease Drugs Market Challenges
2.3.4 Metabolic Disease Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metabolic Disease Drugs Players by Revenue
3.1.1 Global Top Metabolic Disease Drugs Players by Revenue (2020-2025)
3.1.2 Global Metabolic Disease Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Metabolic Disease Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Metabolic Disease Drugs Revenue
3.4 Global Metabolic Disease Drugs Market Concentration Ratio
3.4.1 Global Metabolic Disease Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metabolic Disease Drugs Revenue in 2024
3.5 Global Key Players of Metabolic Disease Drugs Head office and Area Served
3.6 Global Key Players of Metabolic Disease Drugs, Product and Application
3.7 Global Key Players of Metabolic Disease Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Metabolic Disease Drugs Breakdown Data by Type
4.1 Global Metabolic Disease Drugs Historic Market Size by Type (2020-2025)
4.2 Global Metabolic Disease Drugs Forecasted Market Size by Type (2026-2031)
5 Metabolic Disease Drugs Breakdown Data by Application
5.1 Global Metabolic Disease Drugs Historic Market Size by Application (2020-2025)
5.2 Global Metabolic Disease Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Metabolic Disease Drugs Market Size (2020-2031)
6.2 North America Metabolic Disease Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Metabolic Disease Drugs Market Size by Country (2020-2025)
6.4 North America Metabolic Disease Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Metabolic Disease Drugs Market Size (2020-2031)
7.2 Europe Metabolic Disease Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Metabolic Disease Drugs Market Size by Country (2020-2025)
7.4 Europe Metabolic Disease Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metabolic Disease Drugs Market Size (2020-2031)
8.2 Asia-Pacific Metabolic Disease Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Metabolic Disease Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Metabolic Disease Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Metabolic Disease Drugs Market Size (2020-2031)
9.2 Latin America Metabolic Disease Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Metabolic Disease Drugs Market Size by Country (2020-2025)
9.4 Latin America Metabolic Disease Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metabolic Disease Drugs Market Size (2020-2031)
10.2 Middle East & Africa Metabolic Disease Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Metabolic Disease Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Metabolic Disease Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Metabolic Disease Drugs Introduction
11.1.4 Merck Revenue in Metabolic Disease Drugs Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Metabolic Disease Drugs Introduction
11.2.4 Novartis Revenue in Metabolic Disease Drugs Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Metabolic Disease Drugs Introduction
11.3.4 Takeda Pharmaceutical Revenue in Metabolic Disease Drugs Business (2020-2025)
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Astra Zeneca Business Overview
11.4.3 Astra Zeneca Metabolic Disease Drugs Introduction
11.4.4 Astra Zeneca Revenue in Metabolic Disease Drugs Business (2020-2025)
11.4.5 Astra Zeneca Recent Development
11.5 Beohrigher Ingelheim
11.5.1 Beohrigher Ingelheim Company Details
11.5.2 Beohrigher Ingelheim Business Overview
11.5.3 Beohrigher Ingelheim Metabolic Disease Drugs Introduction
11.5.4 Beohrigher Ingelheim Revenue in Metabolic Disease Drugs Business (2020-2025)
11.5.5 Beohrigher Ingelheim Recent Development
11.6 KOWA
11.6.1 KOWA Company Details
11.6.2 KOWA Business Overview
11.6.3 KOWA Metabolic Disease Drugs Introduction
11.6.4 KOWA Revenue in Metabolic Disease Drugs Business (2020-2025)
11.6.5 KOWA Recent Development
11.7 Kythera
11.7.1 Kythera Company Details
11.7.2 Kythera Business Overview
11.7.3 Kythera Metabolic Disease Drugs Introduction
11.7.4 Kythera Revenue in Metabolic Disease Drugs Business (2020-2025)
11.7.5 Kythera Recent Development
11.8 Fuji yakuhin
11.8.1 Fuji yakuhin Company Details
11.8.2 Fuji yakuhin Business Overview
11.8.3 Fuji yakuhin Metabolic Disease Drugs Introduction
11.8.4 Fuji yakuhin Revenue in Metabolic Disease Drugs Business (2020-2025)
11.8.5 Fuji yakuhin Recent Development
11.9 LG Life Science
11.9.1 LG Life Science Company Details
11.9.2 LG Life Science Business Overview
11.9.3 LG Life Science Metabolic Disease Drugs Introduction
11.9.4 LG Life Science Revenue in Metabolic Disease Drugs Business (2020-2025)
11.9.5 LG Life Science Recent Development
11.10 Metsubishi Tanabe Pharma
11.10.1 Metsubishi Tanabe Pharma Company Details
11.10.2 Metsubishi Tanabe Pharma Business Overview
11.10.3 Metsubishi Tanabe Pharma Metabolic Disease Drugs Introduction
11.10.4 Metsubishi Tanabe Pharma Revenue in Metabolic Disease Drugs Business (2020-2025)
11.10.5 Metsubishi Tanabe Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Beohrigher Ingelheim
Kowa
Kythera
Fuji yakuhin
LG Life Science
Metsubishi Tanabe Pharma
List of Tables
 Table 1. Global Metabolic Disease Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Glycogen Metabolism Disease Drug
 Table 3. Key Players of Lipid Metabolism Disease Drug
 Table 4. Key Players of Amino Acid Metabolism Drug
 Table 5. Key Players of Other
 Table 6. Global Metabolic Disease Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Metabolic Disease Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Metabolic Disease Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Metabolic Disease Drugs Market Share by Region (2020-2025)
 Table 10. Global Metabolic Disease Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Metabolic Disease Drugs Market Share by Region (2026-2031)
 Table 12. Metabolic Disease Drugs Market Trends
 Table 13. Metabolic Disease Drugs Market Drivers
 Table 14. Metabolic Disease Drugs Market Challenges
 Table 15. Metabolic Disease Drugs Market Restraints
 Table 16. Global Metabolic Disease Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Metabolic Disease Drugs Market Share by Players (2020-2025)
 Table 18. Global Top Metabolic Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disease Drugs as of 2024)
 Table 19. Ranking of Global Top Metabolic Disease Drugs Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Metabolic Disease Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Metabolic Disease Drugs, Headquarters and Area Served
 Table 22. Global Key Players of Metabolic Disease Drugs, Product and Application
 Table 23. Global Key Players of Metabolic Disease Drugs, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Metabolic Disease Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Metabolic Disease Drugs Revenue Market Share by Type (2020-2025)
 Table 27. Global Metabolic Disease Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Metabolic Disease Drugs Revenue Market Share by Type (2026-2031)
 Table 29. Global Metabolic Disease Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Metabolic Disease Drugs Revenue Market Share by Application (2020-2025)
 Table 31. Global Metabolic Disease Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Metabolic Disease Drugs Revenue Market Share by Application (2026-2031)
 Table 33. North America Metabolic Disease Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Metabolic Disease Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Metabolic Disease Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Metabolic Disease Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Metabolic Disease Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Metabolic Disease Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Metabolic Disease Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Metabolic Disease Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Metabolic Disease Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Metabolic Disease Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Metabolic Disease Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Metabolic Disease Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Metabolic Disease Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Metabolic Disease Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Metabolic Disease Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Merck Company Details
 Table 49. Merck Business Overview
 Table 50. Merck Metabolic Disease Drugs Product
 Table 51. Merck Revenue in Metabolic Disease Drugs Business (2020-2025) & (US$ Million)
 Table 52. Merck Recent Development
 Table 53. Novartis Company Details
 Table 54. Novartis Business Overview
 Table 55. Novartis Metabolic Disease Drugs Product
 Table 56. Novartis Revenue in Metabolic Disease Drugs Business (2020-2025) & (US$ Million)
 Table 57. Novartis Recent Development
 Table 58. Takeda Pharmaceutical Company Details
 Table 59. Takeda Pharmaceutical Business Overview
 Table 60. Takeda Pharmaceutical Metabolic Disease Drugs Product
 Table 61. Takeda Pharmaceutical Revenue in Metabolic Disease Drugs Business (2020-2025) & (US$ Million)
 Table 62. Takeda Pharmaceutical Recent Development
 Table 63. Astra Zeneca Company Details
 Table 64. Astra Zeneca Business Overview
 Table 65. Astra Zeneca Metabolic Disease Drugs Product
 Table 66. Astra Zeneca Revenue in Metabolic Disease Drugs Business (2020-2025) & (US$ Million)
 Table 67. Astra Zeneca Recent Development
 Table 68. Beohrigher Ingelheim Company Details
 Table 69. Beohrigher Ingelheim Business Overview
 Table 70. Beohrigher Ingelheim Metabolic Disease Drugs Product
 Table 71. Beohrigher Ingelheim Revenue in Metabolic Disease Drugs Business (2020-2025) & (US$ Million)
 Table 72. Beohrigher Ingelheim Recent Development
 Table 73. KOWA Company Details
 Table 74. KOWA Business Overview
 Table 75. KOWA Metabolic Disease Drugs Product
 Table 76. KOWA Revenue in Metabolic Disease Drugs Business (2020-2025) & (US$ Million)
 Table 77. KOWA Recent Development
 Table 78. Kythera Company Details
 Table 79. Kythera Business Overview
 Table 80. Kythera Metabolic Disease Drugs Product
 Table 81. Kythera Revenue in Metabolic Disease Drugs Business (2020-2025) & (US$ Million)
 Table 82. Kythera Recent Development
 Table 83. Fuji yakuhin Company Details
 Table 84. Fuji yakuhin Business Overview
 Table 85. Fuji yakuhin Metabolic Disease Drugs Product
 Table 86. Fuji yakuhin Revenue in Metabolic Disease Drugs Business (2020-2025) & (US$ Million)
 Table 87. Fuji yakuhin Recent Development
 Table 88. LG Life Science Company Details
 Table 89. LG Life Science Business Overview
 Table 90. LG Life Science Metabolic Disease Drugs Product
 Table 91. LG Life Science Revenue in Metabolic Disease Drugs Business (2020-2025) & (US$ Million)
 Table 92. LG Life Science Recent Development
 Table 93. Metsubishi Tanabe Pharma Company Details
 Table 94. Metsubishi Tanabe Pharma Business Overview
 Table 95. Metsubishi Tanabe Pharma Metabolic Disease Drugs Product
 Table 96. Metsubishi Tanabe Pharma Revenue in Metabolic Disease Drugs Business (2020-2025) & (US$ Million)
 Table 97. Metsubishi Tanabe Pharma Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Metabolic Disease Drugs Picture
 Figure 2. Global Metabolic Disease Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Metabolic Disease Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Glycogen Metabolism Disease Drug Features
 Figure 5. Lipid Metabolism Disease Drug Features
 Figure 6. Amino Acid Metabolism Drug Features
 Figure 7. Other Features
 Figure 8. Global Metabolic Disease Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Metabolic Disease Drugs Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Pharmacy Case Studies
 Figure 11. Retail Pharmacy Case Studies
 Figure 12. Metabolic Disease Drugs Report Years Considered
 Figure 13. Global Metabolic Disease Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Metabolic Disease Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Metabolic Disease Drugs Market Share by Region: 2024 VS 2031
 Figure 16. Global Metabolic Disease Drugs Market Share by Players in 2024
 Figure 17. Global Top Metabolic Disease Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disease Drugs as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Metabolic Disease Drugs Revenue in 2024
 Figure 19. North America Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Metabolic Disease Drugs Market Share by Country (2020-2031)
 Figure 21. United States Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Metabolic Disease Drugs Market Share by Country (2020-2031)
 Figure 25. Germany Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Metabolic Disease Drugs Market Share by Region (2020-2031)
 Figure 33. China Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Metabolic Disease Drugs Market Share by Country (2020-2031)
 Figure 41. Mexico Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Metabolic Disease Drugs Market Share by Country (2020-2031)
 Figure 45. Turkey Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Metabolic Disease Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Merck Revenue Growth Rate in Metabolic Disease Drugs Business (2020-2025)
 Figure 49. Novartis Revenue Growth Rate in Metabolic Disease Drugs Business (2020-2025)
 Figure 50. Takeda Pharmaceutical Revenue Growth Rate in Metabolic Disease Drugs Business (2020-2025)
 Figure 51. Astra Zeneca Revenue Growth Rate in Metabolic Disease Drugs Business (2020-2025)
 Figure 52. Beohrigher Ingelheim Revenue Growth Rate in Metabolic Disease Drugs Business (2020-2025)
 Figure 53. KOWA Revenue Growth Rate in Metabolic Disease Drugs Business (2020-2025)
 Figure 54. Kythera Revenue Growth Rate in Metabolic Disease Drugs Business (2020-2025)
 Figure 55. Fuji yakuhin Revenue Growth Rate in Metabolic Disease Drugs Business (2020-2025)
 Figure 56. LG Life Science Revenue Growth Rate in Metabolic Disease Drugs Business (2020-2025)
 Figure 57. Metsubishi Tanabe Pharma Revenue Growth Rate in Metabolic Disease Drugs Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Metabolic Disease Therapeutics Market Research Report 2025
Metabolic Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Metabolic Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Metabolic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Metabolic Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metabolism Drugs Market Research Report 2025
Drugs for Glycogen Metabolism Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Glycogen Metabolism Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Glycogen Metabolism Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drugs for Treating Metabolic Disorders Market Research Report 2024
Glycogen Metabolism Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metabolic Disorder Therapeutics Market Insights Forecast to 2030
Lipid Metabolism Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lipid Metabolism Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Lipid Metabolism Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lipid Metabolism Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiometabolic Disease Drug Market Research Report 2024
Amino Acid Metabolism Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Amino Acid Metabolism Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiometabolic Drug Market Insights Forecast to 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions